Aclaris therapeutics to participate in the 2023 cantor global healthcare conference

Wayne, pa., sept. 20, 2023 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the aclaris management team will participate in a fireside chat during the 2023 cantor global healthcare conference on tuesday, september 26, 2023 at 10:30 am et, in new york, ny.
ACRS Ratings Summary
ACRS Quant Ranking